— Know what they know.
Not Investment Advice

GBIM OTC

GlobeImmune, Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0% 3Y: -85.7% 5Y: -99.9%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Sell · Power 45 · $575 mcap · 4M float · 0.012% daily turnover · Short 88% of daily vol

Balance Sheet Trends

Total Assets
$12M -37.4% ▼
5Y CAGR: -13.4%
Total Liabilities
$9M -33.3% ▼
5Y CAGR: -45.8%
Shareholders Equity
$3M -46.7% ▼
Cash & Investments
$10M -41.1% ▼
5Y CAGR: -13.4%
Total Debt
$0 +0.0% ▲
Net Debt
-$10M +41.1% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2011FY2012FY2013FY2014FY2015
— Assets —
Cash$15M$2M$6M$17M$10M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$15M$2M$6M$17M$10M
Net Receivables$0$0$0$0$0
Inventory$0$0$0$0$0
Other Current Assets$422K$886K$901K$1000K$1M
Total Current Assets$16M$3M$7M$18M$11M
Property, Plant & Equip.$2M$1M$493K$456K$210K
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$100K$100K$100K$100K$206K
Total Non-Current Assets$2M$1M$593K$556K$415K
Total Assets$18M$4M$7M$18M$12M
— Liabilities —
Accounts Payable$1M$3M$2M$573K$234K
Short-Term Debt$0$0$0$0$0
Deferred Revenue$11M$4M$4M$3M$3M
Other Current Liabilities$707K$557K$527K$681K$428K
Total Current Liabilities$13M$8M$6M$5M$4M
Long-Term Debt$0$0$198K$0$0
Other Non-Current Liab.$168M$178M$223K$149K$172K
Total Non-Current Liabilities$187M$192M$200M$8M$4M
Total Liabilities$200M$200M$207M$13M$9M
— Equity —
Common Stock$3K$92$93$6K$6K
Retained Earnings-$182M-$196M-$199M-$223M-$225M
Accumulated OCI$0-$177K-$189M-$0$0
Total Stockholders Equity-$182M-$196M-$199M$6M$3M
Total Liabilities & Equity$18M$4M$7M$18M$12M
— Key Metrics —
Total Debt$0$0$198K$0$0
Net Debt-$15M-$2M-$6M-$17M-$10M
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms